Company Profile
ProMIS Neurosciences Stock Price, News & Analysis
- Ticker:
- PMN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, ProMIS Neurosciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
10.69 USD (+0.09%)
Close
Last updated: June 23, 2026 at 00:00
95.86M USD
Market cap
Why the stock is moving
PMN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
ProMIS Neurosciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, ProMIS Neurosciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
ProMIS Neurosciences follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, ProMIS Neurosciences sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ProMIS Neurosciences (PMN)?
ProMIS Neurosciences (PMN) most recently closed at 10.69 USD, a +0.09% move versus the previous session.
What is the market cap of ProMIS Neurosciences (PMN)?
ProMIS Neurosciences currently has a market capitalization of 95.86M USD on BioPharmSignal.
What does ProMIS Neurosciences do?
ProMIS Neurosciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is PMN stock listed?
ProMIS Neurosciences (PMN) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, ProMIS Neurosciences is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is ProMIS?
ProMIS Neurosciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is ProMIS Neurosciences targeting with ProMIS?
ProMIS Neurosciences is associated with neuroscience based on its company overview and current catalyst commentary.
What is Neurosciences?
ProMIS Neurosciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.